Recommendations for the use of cladribine tablets for the pathogenetic treatment of patients with highly active multiple sclerosis

Recommendations for the use of cladribine tablets for the pathogenetic treatment of patients with highly active multiple sclerosis

Currently, special attention is paid to timely treatment for active forms of multiple sclerosis (MS), especially for highly active MS (HAMS), in which there are ≥2 exacerbations and corresponding activity signs that are detected by magnetic resonance imaging (MRI) regardless of previous therapy with...

Full description

Bibliographic Details
Main Authors: K. Z. Bakhtiyarova, A. N. Boyko, Ya. V. Vlasov, Z. A. Goncharova, M. V. Davydovskaya, M. N. Zakharova, N. A. Malkova, A. I. Nilov, S. A. Sivertseva, N. N. Spirin, N. A. Totolyan, F. A. Khabirov, M. V. Shumilina
Format: Article
Language:Russian
Published: IMA-PRESS LLC 2020-06-01
Series:Неврология, нейропсихиатрия, психосоматика
Subjects:
highly active multiple sclerosis
immunoreconstitution therapy
cladribine tablets
pregnancy and childbirth in multiple sclerosis
Online Access:https://nnp.ima-press.net/nnp/article/view/1359

Similar Items

Similar Items